Kristie Wagner
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Kristie Wagner
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 37 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kristie Wagner
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Investment Banks/Brokers | Analyst-Equity | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Human Resources Officer Chief Operating Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chairman Founder Director/Board Member Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| Emory University | College/University | Corporate Officer/Principal | |
| Suffolk University | College/University | Undergraduate Degree Masters Business Admin | |
| Providence College | College/University | Masters Business Admin Undergraduate Degree | |
| Seattle University | College/University | Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor General Counsel | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
LeukoSight, Inc.
 LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | Pharmaceuticals: Major | Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Chairman | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Dänemark | 4 |
| Niederlande | 2 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Finance | 6 |
| Health Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 214 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 91 |
| Chairman | 46 |
| Chief Executive Officer | 37 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Muneer Satter | 35 |
| Michael Wyzga | 31 |
| Steven Gilman | 25 |
| Ronald Renaud | 24 |
| Michael Heffernan | 23 |
| Maxine Gowen | 23 |
| Jodie Morrison | 20 |
| Adrian Adams | 19 |
| Anupam Dalal | 18 |
| Scott Canute | 17 |
| Michael Rogers | 16 |
| William F. Daly | 15 |
| Mark Enyedy | 15 |
| Rita Jain | 14 |
- Börse
- Insiders
- Kristie Wagner
- Unternehmensverbindungen
